Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00490295
Other study ID # IRB00002572
Secondary ID
Status Completed
Phase N/A
First received June 20, 2007
Last updated November 25, 2013
Start date March 2008
Est. completion date January 2010

Study information

Verified date November 2013
Source Emory University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Brain injury occurs in one-quarter to one-half of congenital heart defect infants during the perioperative period. A blood test using a biomarker to diagnose brain injury would be important.

Postoperative cerebral ischemia may be decreased by inotropic support, ventilation, medical management aimed at increasing oxygen delivery to the brain. Currently there are no FDA approved blood tests to assess brain ischemia in infants undergoing cardiac surgery.

Specific Aim 1: We will prospectively study 10 neonates (< 30 days of age) undergoing cardiac surgery utilizing cardiopulmonary bypass for arterial switch operation or Norwood operation to determine the specificity and sensitivity of a blood test for brain injury. This aim will be accomplished by analyzing blood samples for S-100 and NSE drawn prior to surgery, once each day following cardiac surgery as long as the patient remains in the intensive care unit (maximum 5 days)and at the time of postoperative brain magnetic resonance imaging. The S-100B and NSE values will then be correlated with brain magnetic resonance imaging studies before cardiac surgery and at following cardiac surgery.

Hypothesis: We expect the concentration of S-100B and NSE will be significantly higher in the blood of neonates with congenital heart disease who have documented brain injury on brain magnetic resonance imaging (MRI). Furthermore, we predict that the blood levels of S-100B and NSE may correlate to clinical outcome (time to extubation, hospital discharge, neurodevelopmental outcome at 6 months of age).

Specific Aim 2: We will prospectively study these neonates at 6 months following cardiac surgery to determine a correlation between neurodevelopment and concentration of S-100B and NSE. To achieve this specific aim, a blood sample for S-100B and NSE and neurodevelopmental testing will be done at 6 months following cardiac surgery.

Hypothesis: We expect neonates with elevated S-100B and NSE and abnormal brain magnetic resonance imaging documented in specific aim 1 to have a significant decline in neurodevelopment at 6 months after cardiac surgery.

Long-term: The long-term goal of this research is to diagnose brain ischemia in infants using a biomarker blood test.


Description:

1. Ten full-term neonates (> 36 week gestation), between 1-30 days of age, who present for arterial switch operation or Norwood operation will have 2 ml of blood drawn prior to cardiac surgery, 2 ml blood drawn each day after cardiac surgery as long as the patient remains in the intensive care unit with indwelling lines (maximum of 5 days) and 2 ml blood drawn on the day of the followup brain magnetic resonance imaging study (if not within the maximum of 5 days) to determine blood concentrations S100B and NSE.

2. Brain magnetic resonance imaging (MRI) including T1, 2, DWI, spectroscopy, and magnetic resonance angiography, will be performed prior to cardiac surgery and following cardiac surgery in all study patients. Timing of the follow-up brain magnetic resonance imaging including T1, 2, DWI, spectroscopy, and magnetic resonance angiography, will be based on stability of the patient as assessed by the attending physician. Optimal timing for brain magnetic resonance imaging is 4 days postop.

3. Maternal information including level of education, medications, and medical history will be obtained. Two mls of blood will also be obtained from the mother to determine maternal blood concentrations of S100B and NSE.

4. Study patient clinical variables, including vital signs (heart rate, blood pressure, respiratory rate), systemic oxygen saturation by extremity pulse oximetry, near infrared spectroscopy (NIRS), routine laboratory values will be obtained at the time of each study blood sample.

5. Operative variables including cardiopulmonary bypass time, aortic cross clamp time, circulatory arrest time, and hematocrit on bypass will be obtained. Transfusion quantity of packed red blood cells, fresh frozen plasma, platelets, and cryoprecipitate used in the operating room and in the cardiac intensive care unit will also be obtained

6. Outcome variables including length of mechanical ventilation, hospital stay, and gross neurological abnormalities (clinical seizures) will be obtained.

Follow-up:

7. All patients will have neurodevelopmental testing at 6 months after heart surgery.

8. Another 2 mls of blood S100B and NSE will be obtained when the patient returns at 6 months for neurodevelopmental testing.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date January 2010
Est. primary completion date January 2010
Accepts healthy volunteers No
Gender Both
Age group N/A to 30 Days
Eligibility Inclusion Criteria:

- Ten consecutive full-term (>36 week gestation) neonates, one day to 30 days of age, presenting for cardiac surgery for arterial switch operation or Norwood operation will be eligible for the study.

- No patient will be excluded because of race or ethnicity.

- Parental or legal guardian consent will be obtained for all patients prior to enrollment.

Exclusion Criteria:

- Newborns with multiple organ abnormalities in addition to their heart defect such as diaphragmatic hernia, tracheo-esophageal fistula, and congenital syndromes involving multiple organs will be excluded from participation.

- Newborns with genetic syndromes associated with developmental delay will also be excluded.

- Newborns with birth asphyxia, 5 minute Apgar score < 5, will be excluded. Patients with multiple organ failure, syndromes, and birth asphyxia have other causes for neurodevelopmental abnormalities.

- Those patients unable to return for postop follow-up and neurodevelopmental testing will be excluded from participation.

- Those patients with parents/guardians who are unable to read or speak English will be excluded from participation.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Emory University Atlanta Georgia

Sponsors (2)

Lead Sponsor Collaborator
Emory University Children's Healthcare of Atlanta

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnose brain ischemia in infants using a biomarker blood test. 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Not yet recruiting NCT03291678 - Impact of Percutaneous Laparoscopic Assisted Internal Ring Ligation During Lap Orchiopexy N/A
Completed NCT00489788 - Predictors for Pulmonary Valve Replacement - Anatomic and Hemodynamic Using MRI N/A
Terminated NCT00268060 - Infant Medical Records: Case Report Proposal N/A
Not yet recruiting NCT05955794 - Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes N/A
Completed NCT00257517 - Multisite Feeding Study: Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle N/A
Completed NCT00478296 - Pulmonary Hypertension in Trisomy 21 Patients N/A
Completed NCT04556487 - Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Terminated NCT00261989 - Pulse Oximetry Readings and Hourly Variation in Oximetry Readings With CHD N/A
Completed NCT00211081 - Spironolactone in Patients With Single Ventricle Heart N/A
Terminated NCT00268099 - Optimal Timing for Repair of Right-to-Left Shunt Lesions N/A
Active, not recruiting NCT05752019 - TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
Terminated NCT00327899 - Home Inotropic Therapy in Children N/A
Terminated NCT00229905 - Child With Anomalous Drainage of IVC to Left Atrium N/A
Completed NCT00277901 - MRI Assessment of RV Function: Patients With TOF or Aortic Coarctation N/A
Terminated NCT00366314 - Frequency of Accessing Central Lines for Blood Samples N/A
Terminated NCT00268034 - Left Ventricular Aneurysms in Children N/A
Completed NCT00366847 - Computer Modeling of Congenital Heart Disease N/A
Withdrawn NCT00460824 - A Retrospective Review - Anti-HLA Antibodies N/A
Recruiting NCT05749419 - Vaccinations and People With Disabilities